ʻaoʻao_banner

Nā huahana

  • N-Methyl-3,3-diphenylpropylamine

    N-Methyl-3,3-diphenylpropylamine

    Mea Kimia & Kino

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 1-chloro-tert-butyl alcohol, 1-chloro-2-methyl-2-propanol

    1-chloro-tert-butyl alcohol, 1-chloro-2-methyl-2-propanol

    Mea Kimia & Kino

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2 ,4-Triazol-3-kahi

    2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2 ,4-Triazol-3-kahi

    Mea Kimia & Kino

    Ma waena o ka hoʻomākaukau ʻana o Posaconazole.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 5-Chloro-2-thiophenecarboxylic acid

    5-Chloro-2-thiophenecarboxylic acid

    Mea Kimia & Kino

    Ma waena o ka hoʻomākaukau ʻana o Posaconazole.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • (S)-(+)-N-(2,3-Epoxypropyl)phthalimide

    (S)-(+)-N-(2,3-Epoxypropyl)phthalimide

    Mea Kimia & Kino

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • ʻAkika Acetic, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester

    ʻAkika Acetic, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester

    Mea Kimia & Kino

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 4-(4-Aminophenyl)morpholin-3-hoʻokahi

    4-(4-Aminophenyl)morpholin-3-hoʻokahi

    Mea Kimia & Kino

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone

    5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone

    Mea Kimia & Kino

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • ʻO Acetoxy Empagliflozin

    ʻO Acetoxy Empagliflozin

    Mea Kimia & Kino

    ʻO Empagliflozin (inoa kālepa Jardiance) kahi lāʻau lapaʻau o ka papa gliflozin, i ʻae ʻia no ka mālama ʻana i ka maʻi diabetes type 2 i nā pākeke ma 2014. Ua hoʻomohala ʻia e Boehringer Ingelheim a me Eli Lilly a me Company.

    ʻO ka Empagliflozin kahi mea paʻa o ka sodium glucose co-transporter-2 (SGLT-2), a hoʻoneʻe ʻia ke kō i loko o ke koko e nā puʻupaʻa a hoʻopau ʻia i loko o ka mimi.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • ʻO Dapagliflozin Tetraacetate, Dapagliflozin waena

    ʻO Dapagliflozin Tetraacetate, Dapagliflozin waena

    Mea Kimia & Kino

    ʻO Dapagliflozin Tetraacetate kahi derivative o Dapagliflozin [D226255], kahi mea paʻa sodium-glucose transporter 2.
    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!
    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • ʻO ka Empagliflozin

    ʻO ka Empagliflozin

    Mea Kimia & Kino

    ʻO Empagliflozin (inoa kālepa Jardiance) kahi lāʻau lapaʻau o ka papa gliflozin, i ʻae ʻia no ka mālama ʻana i ka maʻi diabetes type 2 i nā pākeke ma 2014. Ua hoʻomohala ʻia e Boehringer Ingelheim a me Eli Lilly a me Company.

    ʻO ka Empagliflozin kahi mea paʻa o ka sodium glucose co-transporter-2 (SGLT-2), a hoʻoneʻe ʻia ke kō i loko o ke koko e nā puʻupaʻa a hoʻopau ʻia i loko o ka mimi.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

  • 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-hoʻokahi

    3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-hoʻokahi

    Mea Kimia & Kino

    Hoʻohana ʻia ka 5-morpholin-4-yl-1-(4-nitrophenyl) -2,3-dihydropyridin-6-one ma ke ʻano he waena no apixaban.

    ʻO Apixaban kahi mea hoʻonāwaliwali o ka waha koho X i hiki ke pale i ka thrombosis, akā ʻoi aku ka liʻiliʻi o nā hopena ʻino o ke koko ma mua o ka warfarin lāʻau kahiko.Hoʻohana ʻia ia no ka pale ʻana i ka thrombosis i nā poʻe maʻi i loaʻa i ke kīpē a i ʻole ke kuli.

    Inā makemake ʻoe i kā mākou huahana a i ʻole he nīnau, e ʻoluʻolu e hoʻokaʻaʻike mai iā mākou!

    Hāʻawi ʻia nā huahana ma lalo o ka patent no ke kumu R&D wale nō.

<< < Mamua123Aʻe >>> ʻAoʻao 2 / 3